Are higher doses of nicotine replacement more effective for smoking cessation?

John R. Hughes, George R. Lesmes, Dorothy K. Hatsukami, Robyn L. Richmond, Edward Lichtenstein, Douglas E. Jorenby, Joseph O. Broughton, Stephen P. Fortmann, Scott J. Leischow, James P. McKenna, Stephen Israel Rennard, William C. Wadland, Scott A. Heatley

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

This study determined whether higher dose nicotine patches are more efficacious than lower dose patches among heavy smokers. A randomized double-blind study compared 0, 21, 35, and 42 ing/day of a 24-h patch in 1039 smokers (≥30 cigarettes/day) at 12 clinical sites in the USA and one in Australia. Daily patches were used for 6 weeks followed by tapering over the next 10 weeks. Weekly group therapy occurred. Biochemically validated self-reported quit rates at 6, 12, 26, and 52 weeks post-cessation were measured. Quit rates were dose-related at all follow-ups (p < 0.01). Continuous, biochemically verified abstinence rates for the 0, 21, 35, and 42 mg doses at the end of treatment (12 weeks) were 16, 24, 30, and 39%. At 6 months, the rates were 13, 20, 20, and 26%. Among the 11 sites with 12 month follow-up (n = 879), the quit rates were 7, 13, 9, and 19%. In post-hoc tests, none of the active doses were significantly different from each other at any follow-up. The rates of dropouts due to adverse events for 0, 21, 35, and 42 mg were 3, 1, 3, and 6% (p = n.s.). Our results are similar to most prior smaller studies; i.e., in heavy smokers higher doses increase quit rates slightly. Longer durations of treatment may be necessary to show greater advantages from higher doses.

Original languageEnglish (US)
Pages (from-to)169-174
Number of pages6
JournalNicotine and Tobacco Research
Volume1
Issue number2
DOIs
StatePublished - Jan 1 1999

Fingerprint

Tobacco Use Cessation Products
Smoking Cessation
Group Psychotherapy
Nicotine
Double-Blind Method
Tobacco Products

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Hughes, J. R., Lesmes, G. R., Hatsukami, D. K., Richmond, R. L., Lichtenstein, E., Jorenby, D. E., ... Heatley, S. A. (1999). Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine and Tobacco Research, 1(2), 169-174. https://doi.org/10.1080/14622299050011281

Are higher doses of nicotine replacement more effective for smoking cessation? / Hughes, John R.; Lesmes, George R.; Hatsukami, Dorothy K.; Richmond, Robyn L.; Lichtenstein, Edward; Jorenby, Douglas E.; Broughton, Joseph O.; Fortmann, Stephen P.; Leischow, Scott J.; McKenna, James P.; Rennard, Stephen Israel; Wadland, William C.; Heatley, Scott A.

In: Nicotine and Tobacco Research, Vol. 1, No. 2, 01.01.1999, p. 169-174.

Research output: Contribution to journalArticle

Hughes, JR, Lesmes, GR, Hatsukami, DK, Richmond, RL, Lichtenstein, E, Jorenby, DE, Broughton, JO, Fortmann, SP, Leischow, SJ, McKenna, JP, Rennard, SI, Wadland, WC & Heatley, SA 1999, 'Are higher doses of nicotine replacement more effective for smoking cessation?', Nicotine and Tobacco Research, vol. 1, no. 2, pp. 169-174. https://doi.org/10.1080/14622299050011281
Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE et al. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine and Tobacco Research. 1999 Jan 1;1(2):169-174. https://doi.org/10.1080/14622299050011281
Hughes, John R. ; Lesmes, George R. ; Hatsukami, Dorothy K. ; Richmond, Robyn L. ; Lichtenstein, Edward ; Jorenby, Douglas E. ; Broughton, Joseph O. ; Fortmann, Stephen P. ; Leischow, Scott J. ; McKenna, James P. ; Rennard, Stephen Israel ; Wadland, William C. ; Heatley, Scott A. / Are higher doses of nicotine replacement more effective for smoking cessation?. In: Nicotine and Tobacco Research. 1999 ; Vol. 1, No. 2. pp. 169-174.
@article{053f2795b83547f9b9a908ffbb3ad456,
title = "Are higher doses of nicotine replacement more effective for smoking cessation?",
abstract = "This study determined whether higher dose nicotine patches are more efficacious than lower dose patches among heavy smokers. A randomized double-blind study compared 0, 21, 35, and 42 ing/day of a 24-h patch in 1039 smokers (≥30 cigarettes/day) at 12 clinical sites in the USA and one in Australia. Daily patches were used for 6 weeks followed by tapering over the next 10 weeks. Weekly group therapy occurred. Biochemically validated self-reported quit rates at 6, 12, 26, and 52 weeks post-cessation were measured. Quit rates were dose-related at all follow-ups (p < 0.01). Continuous, biochemically verified abstinence rates for the 0, 21, 35, and 42 mg doses at the end of treatment (12 weeks) were 16, 24, 30, and 39{\%}. At 6 months, the rates were 13, 20, 20, and 26{\%}. Among the 11 sites with 12 month follow-up (n = 879), the quit rates were 7, 13, 9, and 19{\%}. In post-hoc tests, none of the active doses were significantly different from each other at any follow-up. The rates of dropouts due to adverse events for 0, 21, 35, and 42 mg were 3, 1, 3, and 6{\%} (p = n.s.). Our results are similar to most prior smaller studies; i.e., in heavy smokers higher doses increase quit rates slightly. Longer durations of treatment may be necessary to show greater advantages from higher doses.",
author = "Hughes, {John R.} and Lesmes, {George R.} and Hatsukami, {Dorothy K.} and Richmond, {Robyn L.} and Edward Lichtenstein and Jorenby, {Douglas E.} and Broughton, {Joseph O.} and Fortmann, {Stephen P.} and Leischow, {Scott J.} and McKenna, {James P.} and Rennard, {Stephen Israel} and Wadland, {William C.} and Heatley, {Scott A.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1080/14622299050011281",
language = "English (US)",
volume = "1",
pages = "169--174",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Are higher doses of nicotine replacement more effective for smoking cessation?

AU - Hughes, John R.

AU - Lesmes, George R.

AU - Hatsukami, Dorothy K.

AU - Richmond, Robyn L.

AU - Lichtenstein, Edward

AU - Jorenby, Douglas E.

AU - Broughton, Joseph O.

AU - Fortmann, Stephen P.

AU - Leischow, Scott J.

AU - McKenna, James P.

AU - Rennard, Stephen Israel

AU - Wadland, William C.

AU - Heatley, Scott A.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - This study determined whether higher dose nicotine patches are more efficacious than lower dose patches among heavy smokers. A randomized double-blind study compared 0, 21, 35, and 42 ing/day of a 24-h patch in 1039 smokers (≥30 cigarettes/day) at 12 clinical sites in the USA and one in Australia. Daily patches were used for 6 weeks followed by tapering over the next 10 weeks. Weekly group therapy occurred. Biochemically validated self-reported quit rates at 6, 12, 26, and 52 weeks post-cessation were measured. Quit rates were dose-related at all follow-ups (p < 0.01). Continuous, biochemically verified abstinence rates for the 0, 21, 35, and 42 mg doses at the end of treatment (12 weeks) were 16, 24, 30, and 39%. At 6 months, the rates were 13, 20, 20, and 26%. Among the 11 sites with 12 month follow-up (n = 879), the quit rates were 7, 13, 9, and 19%. In post-hoc tests, none of the active doses were significantly different from each other at any follow-up. The rates of dropouts due to adverse events for 0, 21, 35, and 42 mg were 3, 1, 3, and 6% (p = n.s.). Our results are similar to most prior smaller studies; i.e., in heavy smokers higher doses increase quit rates slightly. Longer durations of treatment may be necessary to show greater advantages from higher doses.

AB - This study determined whether higher dose nicotine patches are more efficacious than lower dose patches among heavy smokers. A randomized double-blind study compared 0, 21, 35, and 42 ing/day of a 24-h patch in 1039 smokers (≥30 cigarettes/day) at 12 clinical sites in the USA and one in Australia. Daily patches were used for 6 weeks followed by tapering over the next 10 weeks. Weekly group therapy occurred. Biochemically validated self-reported quit rates at 6, 12, 26, and 52 weeks post-cessation were measured. Quit rates were dose-related at all follow-ups (p < 0.01). Continuous, biochemically verified abstinence rates for the 0, 21, 35, and 42 mg doses at the end of treatment (12 weeks) were 16, 24, 30, and 39%. At 6 months, the rates were 13, 20, 20, and 26%. Among the 11 sites with 12 month follow-up (n = 879), the quit rates were 7, 13, 9, and 19%. In post-hoc tests, none of the active doses were significantly different from each other at any follow-up. The rates of dropouts due to adverse events for 0, 21, 35, and 42 mg were 3, 1, 3, and 6% (p = n.s.). Our results are similar to most prior smaller studies; i.e., in heavy smokers higher doses increase quit rates slightly. Longer durations of treatment may be necessary to show greater advantages from higher doses.

UR - http://www.scopus.com/inward/record.url?scp=0033139420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033139420&partnerID=8YFLogxK

U2 - 10.1080/14622299050011281

DO - 10.1080/14622299050011281

M3 - Article

VL - 1

SP - 169

EP - 174

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 2

ER -